Plasminogen activators and inhibitors in peritoneal tissue

APMIS

Volumn 105, Issue 1, 1997, Pages 25-30

  Holmdahl, Lena ^a   Falkenberg, Mårten ^a   Ivarsson, Marie Louise ^a   Risberg, B O ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Peritoneum; Plasminogen activator inhibitors; Plasminogen activators; Wound healing

Indexed keywords

FIBRIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR;

ABRASION; ARTICLE; CONTROLLED STUDY; FIBRINOLYSIS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INFLAMMATION; MACROPHAGE; PERITONEUM; PRIORITY JOURNAL; TISSUE REPAIR;

EID: 0030777959     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1997.tb00535.x     Document Type: Article

References (25)

1. Buckman, R. F., Woods, M., Sargent, L. & Gervin, A. S.: A unifying pathogenetic mechanism in the etiology of intraperitoneal adhesions. J. Surg. Res. 20: 1-5, 1976.
2. Buø, L., Lyberg, T., Jörgensen, L., Johansen, H. T. & Aasen, A. O.: Location of plasminogen activator (PA) and PA inhibitor in human colorectal adenocarcinomas. APMIS 101: 235-241, 1993.
3. Cordell, J. L., Falini, B., Erber, W. N., Ghosh, A. K., Abdulazis, Z., MacDonald, S., Pulford, K. A. F., Stein, H. & Mason, D. Y.: Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem. 32: 219-229, 1984.
4. Falkenberg, M., Tjärnström, J., Örtenwall, P., Olausson, M. & Risberg, B.: Localization of fibrinolytic activators and inhibitors in normal and atherosclerotic vessels. Thromb. Haemost. 75: 933-938, 1996.
5. Heipel, J. M. & Ossowski, L.: Human neutrophil plasminogen activator is localized in specific granules and is translocated to the cell surface by exocytosis. J. Exp. Med. 164: 826-840, 1986.
6. Holmdahl, L., Al-Jabreen, M. & Risberg, B.: The role of fibrinolysis in the formation of postoperative adhesions. Wound Rep. Reg. 7: 171-176, 1994.
7. Holmdahl, L., Eriksson, E. & Risberg, B.: Fibrinolysis in human peritoneum during surgery. Surgery 119: 701-705, 1996.
8. Idell, S., Zwieb, C., Boggaram, J., Holiday, D., Johnson, A. R. & Raghu, G.: Mechanisms of fibrin formation and lysis by human lung fibroblasts: influence of TGF-beta and TNF-alpha. Am. J. Physiol. 263: L487-L494, 1992.
9. Knudsen, B. S., Harpel, P. C. & Nachman, R. L.: Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells. J. Clin. Invest. 80: 1082-1089, 1987.
10. Kuraoka, S., Campeau, J. D., Rodgers, K. E., Nakamura, R. M. & diZerega, G. S.: Effects of interleukin-1 (IL-1) on postsurgical macrophage secretion of protease and protease inhibitor activities. J. Surg. Res. 52: 71-78, 1992.
11. Lundgren, C. H., Sawa, H., Sobel, B. E. & Fujii, S.: Modulation of expression of monocyte macrophage plasminogen activator activity and its implications for attenuation of vasculopathy. Circulation 90: 1927-1934, 1994.
12. Merlo, G., Fausone, G., Barbero, C. & Castagna, B.: Fibrinolytic activity of the human peritoneum. Eur. Surg. Res. 12: 433-438, 1980.
13. Myhre-Jensen, O., Bergman Larsen, S. & Astrup, T.: Fibrinolytic activity in serosal and synovial membranes. Arch. Pathol. Lab. Med. 88: 623-630, 1969.
14. Perry, J. F., Smith, A. & Yonehiro, E. G.: Intestinal obstruction caused by adhesions: A review of 388 cases. Ann. Surg. 135: 810-816, 1995.
15. Pugatch, E. M. J., Foster, E. A., MacFarlane, D. E. & Poole, J. C. F.: The extraction and separation of activators and inhibitors of fibrinolysis from bovine endothelium and mesothelium. Br. J. Haematol. 18: 669-681, 1970.
16. Pugatch, E. M. J. & Poole, J. C. F.: Inhibitor of fibrinolysis from mesothelium. Nature 221: 269-270, 1969.
17. Raftery, A.: Method for measuring fibrinolytic activity in a single layer of cells. J. Clin. Pathol. 34: 625-629, 1981.
18. Saksela, O., Hovi, T. & Vaheri, Z.: Urokinasetype plasminogen activator and its inhibitor se-creted by cultured human monocyte-macrophages. J. Cell. Physiol. 122: 125-132, 1985.
19. Schäfer, B. M., Maier, K., Eickhoff, U., Todd, R. F. & Kramer, M. D.: Plasminogen activation in healing human wounds. Am. J. Pathol. 144: 1269-1280, 1994.
20. Thompson, J. N., Paterson Brown, S., Harbourne, T., Whawell, S. A., Kalodiki, E. & Dudley, H. A. F.: Reduced human peritoneal plasminogen activating activity: possible mechanism of adhesion formation. Br. J. Surg. 76: 382-384, 1989.
21. van Hinsbergh, V. W. M., Kooistra, T., Scheffer, M. A., van Bockel, J. H. & van Muijen, G. N. P.: Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood 75: 1490-1497, 1990.
22. Vipond, M. N., Whawell, S. A., Thompson, J. N. & Dudley, H. A.: Peritoneal fibrinolytic activity and intra-abdominal adhesions. Lancet 335: 1120-1122, 1990.
23. Weibel, M. & Majno, A. G.: Peritoneal adhesions and their relation to abdominal surgery. A postmortem study. Am. J. Surg. 126: 345-353, 1973.
24. Whawell, S. A., Wang, Y., Fleming, K. A., Thompson, E. M. & Thompson, J. N.: Localization of plasminogen activator inhibitor-1 production in inflamed appendix by in situ mRNA hybridization. J. Pathol. 169: 67-71, 1993.
25. Wiman, B., Almquist, Å., Sigurdardottir, O. & Lindahl, T.: Plasminogen activator inhibitor 1 (PAI) is bound to vitronectin in plasma. FEBS Lett. 242: 125-128, 1988.